Inventor
KAWAKAMI YUTAKA
JP29 patents
⚠️ This page may combine multiple inventors who share the name “KAWAKAMI YUTAKA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
14 patentsUS5994523ANov 30, 1999
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH130 citations99
US5874560AFeb 23, 1999
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH95 citations99
US5844075ADec 1, 1998
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH180 citations99
US7749719B2Jul 6, 2010
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH34 citations96
US6537560B1Mar 25, 2003
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH49 citations96
US6270778B1Aug 7, 2001
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH48 citations96
US7807805B2Oct 5, 2010
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH2 citations74
US7232887B2Jun 19, 2007
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH6 citations74
US6965017B2Nov 15, 2005
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH6 citations74
US7803614B2Sep 28, 2010
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH2 citations63
US7612044B2Nov 3, 2009
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH1 citations63
US8030280B2Oct 4, 2011
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH0 citations52
US7763586B2Jul 27, 2010
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH0 citations52
US7745212B2Jun 29, 2010
Melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH0 citations52
UNIV KEIO
7 patentsUS11167018B2Nov 9, 2021
Compositions and methods for the induction of CD8+ T-cells
UNIV KEIO6 citations84
US10695412B2Jun 30, 2020
Compositions and methods for the induction of CD8+ T-cells
UNIV KEIO7 citations84
US10576136B2Mar 3, 2020
Compositions and methods for the induction of CD8+ T-cells
UNIV KEIO5 citations84
US11633465B2Apr 25, 2023
Compositions and methods for the induction of CD8+ T-cells
UNIV KEIO0 citations62
US11723934B2Aug 15, 2023
Compositions and methods for the induction of CD8+ T-cells
UNIV KEIO0 citations59
US9169324B2Oct 27, 2015
Reducer of immunosuppression by tumor cell and antitumor agent using the same
UNIV KEIO2 citations58
US11370845B2Jun 28, 2022
Anti-glypican-1-immunizing antigen receptor
UNIV KEIO0 citations48